Committee

Executive Members


Chairman Naoya Fujita (Cancer Chemotherapy Ctr.)
General Shingo Dan (Cancer Chemotherapy Ctr.)
Hiroyuki Seimiya (Cancer Chemotherapy Ctr.)
Finance Shunji Takahashi (Cancer Inst. Hospital)
Makoto Nishio (Cancer Inst. Hospital)
Program Ryohei Katayama (Cancer Chemotherapy Ctr.)

Special Advisor

Mitsuaki Yoshida (Cancer Chemotherapy Ctr., Former Chairman of ISCC)
Saburo Sone (Tokushima Univ.)

Committee Members

North America
Bruce A. Chabner (MGH Cancer Ctr., US)
Ryan B. Corcoran (MGH Cancer Ctr., US)
Ross L. Levine (Memorial Sloan Kettering Cancer Ctr., US)
Yves G. Pommier (NCI, US)
Lillian L. Siu (Univ. Toronto, Canada)

Europe
Jaap Verweij (Erasmus Univ. Medical Ctr., Netherlands)
Paul Workman (Inst. Cancer Res., UK)

Japan
 Keisuke Aiba (Todachuo General Hospital)
Yataro Daigo (Shiga Univ. Med. Sci.)
Shingo Dan (Cancer Chemotherapy Ctr.)
Toshihiko Doi (National Cancer Ctr., Hospital East)
Hiromichi Ebi (Aichi Cancer Ctr. Res. Inst.)
Naoya Fujita (Cancer Chemotherapy Ctr.)
Masahiro Fukuoka (Izumi Hospital)
Noriko Gotoh (Kanazawa Univ.)
Takeshi Imamura (Ehime Univ.)
Chikashi Ishioka (Tohoku Univ.)
Hideaki Kakeya (Kyoto Univ.)
Ryohei Katayama (Cancer Chemotherapy Ctr.)
Manabu Kawada (Inst. Microbial Chem.)
Shinya Kimura (Saga Univ.)
Shigehisa Kitano (Cancer Inst. Hospital)
Norio Komatsu (Juntendo Univ.)
Mineo Kurokawa (Univ. Tokyo)
Tetsuo Mashima (Cancer Chemotherapy Ctr., JFCR)
Hironobu Minami (Kobe Univ.)
Tetsuya Mitsudomi (Kinki Univ.)
Kohei Miyazono (Univ. Tokyo)
Tamio Mizukami (Frontier Pharma, Inc.)
Isao Momose (Inst. Microbial Chem.)
Kei Muro (Aichi Cancer Ctr. Hospital)
Masayoshi Nagata (Juntendo Univ.)
Mikihiko Naito (Univ. Tokyo)
Hiroyuki Nakamura (Tokyo Inst. Technol.)
Tomoki Naoe (NHO Nagoya Medical Center)
Naoki Hosen (Osaka Univ.)
Hiroyoshi Nishikawa (National Cancer Ctr.)
Kazuto Nishio (Kinki Univ.)
Makoto Nishio (Cancer Inst. Hospital)
Yasuhiko Nishioka (Tokushima Univ.)
Tomokazu Ohishi (Inst. Microbial Chem.)
Atsushi Ohtsu (National Cancer Ctr., Hospital East)
Isamu Okamoto (Kyushu Univ.)
Hiroyuki Osada (Univ. Shizuoka)
Masanobu Oshima (Kanazawa Univ.)
Toshiaki Saeki (Saitama Med. Univ.)
Nagahiro Saijo (Meguro Med. Clinic)
Shuichi Sakamoto (Inst. Microbial Chem.)
Yasutsuna Sasaki (Showa Univ.)
Hideyuki Saya (Fujita Cancer Ctr.)
Hiroyuki Seimiya (Cancer Chemotherapy Ctr.)
Siro Simizu (Keio Univ.)
Yoshihiro Sowa (Kyoto Pref. Univ. Med.)
Hidetoshi Tahara (Hiroshima Univ.)
Shunji Takahashi (Cancer Inst. Hospital)
Tadatsugu Taniguchi (Univ. Tokyo)
Hiroaki Taniguchi (Kanazawa Univ.)
Yasuhito Terui (Saitama Med. Univ.)
Akihiro Tomida (Cancer Chemotherapy Ctr.)
Shinichi Torii (Univ. Tokyo)
Masahiro Tsuboi (National Cancer Ctr. )
Noriko Usui (Jikei Univ.)
Tatsuro Watanabe (Saga Univ.)
Kosuke Watari (Kyushu Univ.)
Yasuhiro Yamada (Univ. Tokyo)
Ken Yamaguchi (Shizuoka Cancer Ctr.)
Kensei Yamaguchi (Cancer Inst. Hospital)
Kazuhito Yamamoto (Aichi Cancer Ctr. )
Takao Yamori (JPEC)
Seiji Yano (Kanazawa Univ.)
Minoru Yoshida (RIKEN)

Advisory Committee Member

Stanley B. Kaye (The Royal Marsden Hospital, U.K.)
Herbert M. Pinedo (VUmc Cancer Ctr. Amsterdam, Netherlands)
Mitsuyuki Abe (Hyogo Ion Beam Med. Ctr.)
Shiro Akinaga (NANO MRNA Co., Ltd.)
Kiyohiko Hatake (Akasaka Sanno Med. Ctr.)
Tadao Kakizoe (Jpn. Cancer Society)
Tomoyuki Kitagawa (Cancer Institute)
Minoru Kurihara (Tokyo Cooperative Oncology Group)
Toru Masaoka (Osaka Medical Ctr. for Cancer and Cardiovascular Diseases)
Toshifusa Nakajima (Cancer Institute Hospital)
Yoshiro Niitsu (Shonan Kamakura General Hospital)
Makoto Ogawa (Aichi Cancer Ctr.)
Ryuzo Ohno (Aichi Cancer Ctr.)
Hidehiko Saito (Nagoya Central Hospital)
Kiyohiko Sakamoto (Tohoku Univ.)
Motoharu Seiki (Univ. Tokyo)
Masanori Shimoyama (National Cancer Ctr.)
Keizo Sugimachi (Onga Hospital)
Yoshikazu Sugimoto (Keio Univ.)
Masaaki Terada (National Cancer Ctr.)
Kensei Tobinai (National Cancer Ctr. Hospital)
Takeshi Tominaga (Showa Univ.)
Ryuzo Ueda (Nagoya Univ.)
Shigeaki Yoshida (Aomori Prefectural Central Hospital)

Corporate Members

Takashi Shimamoto (MSD K.K.)
Masahiro Esaki (Kyowa Kirin Co., Ltd.)
Daishi Yui (Amgen K.K.)
Ryuichi Moriya (Astellas Pharma Inc.)
Yuki Yamashita (Bristol-Myers Squibb K.K.)
Mika Sakurai (Chugai Pharmaceutical Co., Ltd.)
Yoshihiko Fujisaki (Daiichi Sankyo Co., Ltd.)
Akira Yokoi (Eisai Co., Ltd)
Takeshi Mera (Nippon Boehringer Ingelheim Co., Ltd)
Ryohei Kozaki (Ono Pharmaceutical Co., Ltd.)
Kouji Miyata (Takeda Pharmaceutical Company Limited)
Rii Morimura (Toppan Holdings Inc.)
Hidekazu Takahashi (Taiho Pharmaceutical Co., Ltd.)

Secretariat

Ritsuko Mihara (Cancer Chemotherapy Ctr.)

Page Top